BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
24 results:

  • 1. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
    Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
    Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical outcome of Cytoreductive Surgery Prior to Bevacizumab for Patients with Recurrent Glioblastoma: A Single-center Retrospective Analysis.
    Yamaguchi S; Motegi H; Ishi Y; Okamoto M; Sawaya R; Kobayashi H; Terasaka S; Houkin K
    Neurol Med Chir (Tokyo); 2021 Apr; 61(4):245-252. PubMed ID: 33658457
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).
    Butterfield LH; Zhao F; Lee S; Tarhini AA; Margolin KA; White RL; Atkins MB; Cohen GI; Whiteside TL; Kirkwood JM; Lawson DH
    Clin Cancer Res; 2017 Sep; 23(17):5034-5043. PubMed ID: 28536308
    [No Abstract]    [Full Text] [Related]  

  • 4. Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
    Mangana J; Cheng PF; Schindler K; Weide B; Held U; Frauchiger AL; Romano E; Kähler KC; Rozati S; Rechsteiner M; Moch H; Michielin O; Garbe C; Hauschild A; Hoeller C; Dummer R; Goldinger SM
    PLoS One; 2015; 10(10):e0139438. PubMed ID: 26426340
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases.
    Wilgenhof S; Corthals J; Van Nuffel AM; Benteyn D; Heirman C; Bonehill A; Thielemans K; Neyns B
    Cancer Immunol Immunother; 2015 Mar; 64(3):381-8. PubMed ID: 25548092
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
    Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
    Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Superiority of tympanic ball electrodes over mastoid needle electrodes for intraoperative monitoring of hearing function.
    Krieg SM; Kempf L; Droese D; Rosahl SK; Meyer B; Lehmberg J
    J Neurosurg; 2014 May; 120(5):1042-7. PubMed ID: 24559226
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Chemotherapy for malignant gliomas: an update].
    Wakabayashi T; Natsume A; Fujii M
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1283-7. PubMed ID: 24105052
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survivin expression in medulloblastoma: a possible marker for survival.
    Abdel-Aziz A; Mohamed MA; Akl FM; Taha AN
    Pathol Oncol Res; 2013 Jul; 19(3):413-9. PubMed ID: 23242569
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Estimated cardiac output and cardiovascular profile score in fetuses with high cardiac output lesions.
    Statile CJ; Cnota JF; Gomien S; Divanovic A; Crombleholme T; Michelfelder E
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):54-8. PubMed ID: 23001941
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.
    Ardon H; Van Gool SW; Verschuere T; Maes W; Fieuws S; Sciot R; Wilms G; Demaerel P; Goffin J; Van Calenbergh F; Menten J; Clement P; Debiec-Rychter M; De Vleeschouwer S
    Cancer Immunol Immunother; 2012 Nov; 61(11):2033-44. PubMed ID: 22527250
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases.
    Mocellin S; Pasquali S; Rossi CR; Nitti D
    Surgery; 2011 Jul; 150(1):83-90. PubMed ID: 21683860
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care.
    Scolyer RA; Long GV; Thompson JF
    Mol Oncol; 2011 Apr; 5(2):124-36. PubMed ID: 21482206
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.
    Chi Z; Li S; Sheng X; Si L; Cui C; Han M; Guo J
    BMC Cancer; 2011 Feb; 11():85. PubMed ID: 21349197
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China.
    Zhao J; Li S; Shi J; Wang N
    Br J Ophthalmol; 2011 Oct; 95(10):1372-5. PubMed ID: 21252083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
    Kamba T; Kamoto T; Okubo K; Teramukai S; Kakehi Y; Matsuda T; Ogawa O
    Int J Urol; 2010 Dec; 17(12):980-7. PubMed ID: 20955354
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patients.
    Egberts F; Momkvist A; Egberts JH; Kaehler KC; Hauschild A
    Anticancer Res; 2010 May; 30(5):1799-805. PubMed ID: 20592382
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
    Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
    Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.
    Egberts F; Momkvist A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
    Tumour Biol; 2010 Jan; 31(1):8-15. PubMed ID: 20237897
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
    Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
    Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.